| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 216.63B | 266.44B | 202.80B | 156.23B | 138.32B | 164.88B |
| Gross Profit | 186.62B | 227.05B | 170.48B | 143.19B | 127.54B | 150.02B |
| EBITDA | 62.87B | 88.37B | 62.16B | 33.91B | 33.82B | 42.02B |
| Net Income | 45.83B | 58.90B | 39.07B | 23.05B | 21.43B | 20.53B |
Balance Sheet | ||||||
| Total Assets | 16.71T | 16.96T | 16.44T | 16.38T | 16.17T | 17.28T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 3.58T | 3.19T | 4.55T | 4.36T | 5.47T |
| Total Debt | 1.50T | 1.44T | 1.50T | 1.69T | 1.67T | 3.24T |
| Total Liabilities | 16.06T | 16.23T | 15.78T | 15.72T | 15.56T | 16.66T |
| Stockholders Equity | 648.67B | 727.94B | 654.36B | 660.99B | 608.62B | 619.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 35.44B | 235.34B | 0.00 | -1.47T | 452.61B |
| Operating Cash Flow | 0.00 | 48.88B | 241.29B | 0.00 | -1.47T | 462.41B |
| Investing Cash Flow | 0.00 | -44.41B | -1.55T | 131.36B | 367.72B | -82.65B |
| Financing Cash Flow | 0.00 | 350.69B | -48.70B | 344.53B | -10.98B | -14.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥633.31B | 11.90 | ― | 3.21% | 19.57% | 23.07% | |
68 Neutral | ¥1.21T | 13.40 | ― | 2.00% | 26.77% | 52.41% | |
68 Neutral | ¥581.88B | 11.64 | ― | 3.15% | 14.92% | 43.45% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ¥881.47B | 13.32 | 8.19% | 3.14% | 22.63% | 36.09% | |
65 Neutral | ¥816.52B | 12.04 | ― | 1.41% | 26.64% | 57.23% | |
55 Neutral | ¥238.77B | -94.53 | ― | 2.38% | 33.44% | 57.44% |